Viewing Study NCT07168161


Ignite Creation Date: 2025-12-24 @ 12:49 PM
Ignite Modification Date: 2025-12-29 @ 8:25 AM
Study NCT ID: NCT07168161
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2025-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module